O‑GlcNAcase Inhibitor ASN90 is a Multimodal Drug Candidate for Tau and α‑Synuclein Proteinopathies.
Autor: | Permanne, Bruno, Sand, Astrid, Ousson, Solenne, Nény, Maud, Hantson, Jennifer, Schubert, Ryan, Wiessner, Christoph, Quattropani, Anna, Beher, Dirk |
---|---|
Zdroj: | ACS Chemical Neuroscience; 4/20/2022, Vol. 13 Issue 8, p1296-1314, 19p |
Databáze: | Supplemental Index |
Externí odkaz: |